Exogenous lipoid pneumonia: an important cause of interstitial lung disease in infants

Diana Marangu1,2, Komala Pillay3, Ebrahim Banderker4

  • 1Department of Paediatrics and Child Health University of Nairobi Nairobi Kenya.

Respirology Case Reports
|August 11, 2018
PubMed

Insights

Exogenous lipoid pneumonia (ELP) in infants, often linked to cultural oil administration, presents as persistent pneumonia. Early recognition is crucial for timely intervention and improved outcomes in at-risk populations.

Area of Science:

  • Pediatrics
  • Pulmonology
  • Radiology

Background:

  • Exogenous lipoid pneumonia (ELP) is an underdiagnosed interstitial lung disease.
  • This study focuses on pediatric ELP cases in South Africa.

Observation:

  • Retrospective analysis of 12 infants (2.1-10.8 months) of Zimbabwean heritage with confirmed ELP.
  • Caregivers reported repeated oral plant-based oil administration for cultural reasons in 10/11 cases.
  • Common symptoms included cough, tachypnea, and hypoxia, with diffuse alveolar infiltrates on chest X-rays.

Findings:

  • Chest CT showed ground-glass opacification and lower zone predominance.
  • Bronchoalveolar lavage revealed lipid-laden macrophages and extracellular lipid.
  • Co-infections with polymicrobial organisms and Mycobacterium abscessus were noted in some cases.

Implications:

  • Clinicians should consider ELP in infants with non-resolving pneumonia, especially in communities with similar cultural practices.
  • Prompt diagnosis and intervention are vital for managing pediatric ELP.
  • Further research into the long-term effects and optimal treatment of ELP in children is warranted.

Related Concept Videos

Lung Capacity01:47

Lung Capacity

The air in the lungs is measured in volumes and capacities. Lung volume measures reflect the amount of air taken in, released, or left over after a lung function, like a single inhalation. Lung capacity measures are sums of two or more lung volume measures.
56.4K
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
903
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
3.0K
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
824
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
3.6K
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
307